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a b s t r a c t
Extracellular cAMP functions as a primary ligand for cell surface cAMP receptors throughout Dictyos-
telium discoideum development, controlling chemotaxis and morphogenesis. The developmental con-
sequences of cAMP signaling and the metabolism of cAMP have been studied in great detail, but it has
been unclear how cells export cAMP across the plasma membrane. Here we show pharmacologically and
genetically that ABC transporters mediate cAMP export. Using an evolutionary-developmental biology
approach, we identiﬁed several candidate abc genes and characterized one of them, abcB3, in more
detail. Genetic and biochemical evidence suggest that AbcB3 is a component of the cAMP export
mechanism in D. discoideum development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
When starved, the single-celled social ameba Dictyostelium
discoideum undergoes a remarkable developmental process that
includes chemotaxis, aggregation, kin recognition, and morpho-
genesis, resulting in a multicellular fruiting body (Kessin, 2001).
Over 40 years ago, cAMP was identiﬁed as the chemotactic signal
for aggregation (Barkley, 1969). Extracellular cAMP also functions
as a ﬁrst messenger to specify cell fate during development
(Alvarez-Curto et al., 2005; Schaap, 2011; Saran and Schaap,
2004; Virdy et al., 1999). Despite the developmental importance
of extracellular cAMP, how cAMP export occurs has remained
unknown.
Several groups have proposed mechanisms for cAMP export,
including a vesicular transport mechanism. However, cAMP export
occurs simultaneously with intracellular synthesis with virtually no
lag time during the initial stages of development (Dinauer et al.,
1980), suggesting that vesicular transport is not at play. Adenylyl
cyclase A (ACA) synthesizes intracellular cAMP and contains a
structure similar to ATP Binding Cassette (ABC) transporters
(Kessin, 2001; Pitt et al., 1992), which are known to export anionic
cargoes like cAMP in other organisms (Cheepala et al., 2013). While
ACA is an attractive candidate for cAMP export, acaA-null mutants
can export cAMP when another adenylyl cyclase, ACG, is engineered
to produce intracellular cAMP, indicating that ACA is not the only
possible cAMP exporter (Pitt et al., 1993). Interestingly, several
human ABC transporters can export cAMP (Chen et al., 2001; van
Aubel et al., 2002; Wielinga et al., 2003), prompting us to hypothe-
size that ABC transporters export cAMP in Dictyostelium.
ABC transporters contain two ATP-binding domains and two
membrane-spanning domains that transport a variety of cargo
molecules (Cheepala et al., 2013; Anjard and Loomis, 2002; Annilo
et al., 2006; Graf et al., 2003; Sarkadi et al., 2006). In D. discoideum
there are 68 abc genes, which have been classiﬁed into 8 groups
(abcA through abcH) based on sequence and predicted structural
features (Anjard and Loomis, 2002), but their functions are largely
unknown. We recently characterized the transcriptional and
morphological phenotypes of 35 abc mutants during development
and found that most mutants exhibited subtle phenotypes, sug-
gesting that many of the ABC transporters could have overlapping
functions (Miranda et al., 2013). We hypothesized that cAMP
exporters may be among the uncharacterized abc genes.
Here we show that ABC transporter inhibitors disrupt development
in a manner consistent with a lack of cAMP export. We also identify
several abc genes with cAMP-responsive transcription in D. discoideum
and in Dictyostelium purpureum. Using genetic and biochemical
approaches, we show that one of these genes, abcB3, exports cAMP.
Results
ABC-transporter inhibitors disrupt D. discoideum development
Bacterial and human ABC transporters that export similar cargo
molecules exhibit overlap in inhibitor sensitivity (van Veen et al.,
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1998), suggesting that pharmacological properties of ABC trans-
porters may be similar when they share cargo molecules. The
drugs Indomethicin, Probenecid, Dipyridamole, and Sulfynpyra-
zone inhibit the human cAMP exporters, ABCC4 and ABCC5
(Wielinga et al., 2003; Reid et al., 2003). To test whether ABC
transporters export cAMP in D. discoideum, we examined the effect
of these inhibitors on development. Development of wild-type
D. discoideum (AX4) cells without inhibitors for 22 h resulted in
synchronous development and the formation of culminants
(Fig. 1A). Addition of inhibitors disrupted development and caused
asynchronous morphogenesis (Fig. 1B–E). Sulfynpyrazone caused
the earliest arrest at the loose aggregate stage (Fig. 1E) and
dipyridamole treatment had the least effect, resulting in semi-
clear, frail fruiting bodies (Fig. 1B). Transferring cells that were
initially developed on inhibitor-containing ﬁlters to inhibitor-free
conditions reversed the developmental arrests, and the cells
developed into fruiting bodies after another 24 h. The reversibility
of the drug effects indicates that the treatment was not lethal.
Before individual cells form multicellular structures, they stream
towards aggregation centers in an extracellular cAMP-dependent
manner (Kessin, 2001). We tested the effect of ABC-transporter
inhibitors on the streaming of developing cells in submerged
cultures. In the absence of inhibitor, we observed aggregation
centers with radial tracks of cells aggregating towards the center
(Fig. 2A). Addition of any one of the inhibitors abolished develop-
mental streaming and aggregation (Fig. 2B–E). In the previous
experiment we used a high concentration of inhibitors (Fig. 1)
because the drugs were added to buffer-soaked paper pads beneath
the developmental ﬁlters. However, inhibition of developmental
streaming in submerged cultures occurred at drug concentrations
of 50 μM, similar to the concentrations used in human cell culture
experiments (Wielinga et al., 2003; Reid et al., 2003). These results
demonstrate that inhibitors of ABC transporters disrupt cAMP-
mediated development and support the hypothesis that ABC trans-
porters export cAMP in D. discoideum.
Several abc genes are cAMP responsive
To identify candidate cAMP exporters among the 68 ABC trans-
porter genes in D. discoideumwe relied on the observation that excess
cargo molecules induce the transcription of their respective ABC
transporters in other organisms (Venkateswaran et al., 2000a, 2000b;
Zhou et al., 2008). We developed D. discoideum cells for 0, 3, and 6 h
and treated them with the membrane permeable cAMP analog, 8-Br-
cAMP, for 2 h to mimic intracellular cAMP cargo overload (Riley and
Barclay, 1990). We then measured the transcript abundance of each of
the 68 ABC transporters by quantitative RT-PCR (qRT-PCR) and
compared them between treated and untreated cells. We found that
abc-transcript abundance was not altered at 0 and 3 h, but abcA5,
abcB3, abcC5, abcC12, abcC13, and abcG21 transcripts accumulated in
cells developed for 6 h in the presence of 8-Br-cAMP (Fig. 3A).
To further reﬁne our candidate gene list, we took a comparative
evolutionary-developmental biology approach. Similar to D. dis-
coideum, D. purpureum utilizes cAMP signaling for chemotactic
Fig. 1. ABC transporter inhibitors disrupt D. discoideum development. Cells were developed on black ﬁlters in the presence of (A) no drug, (B) dipyridamole, (C) indomethacin,
(D) probenecid, and (E) sulfynpyrazone. Images shown were taken 22 h into development and are representative images of 3 independent experiments.
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aggregation. However, these two species diverged about 300–450
million years ago and possess divergent genomes (Schaap et al.,
2006; Sucgang et al., 2013). We hypothesized that abc genes
responsible for cAMP export would be shared between the two
species. To test this hypothesis, we repeated the cargo overload
experiments with D. purpureum and measured transcript abun-
dance of the orthologs of the abc genes up-regulated in
D. discoideum. The qRT-PCR results showed that abcA5, abcB3,
and abcG21 transcript abundance increased with the addition of
8-Br-cAMP, whereas abcC5 and abcC12 did not (Fig. 3B). There is no
obvious ortholog for abcC13 in the D. purpureum genome. These
ﬁndings suggest that abcA5, abcB3, and abcG21 encode cAMP
exporters, since cargo overload up-regulated the respective tran-
scripts in two evolutionary divergent organisms that use cAMP for
chemotaxis.
The cAMP analog 8-Br-cAMP is a potent activator of Protein
Kinase A (PKA) (Richardson et al., 1994), and at least one abc gene,
abcA1, is up-regulated through the PKA pathway in another
system even though cAMP is not a cargo molecule for this
transporter (Oram et al., 2000). To distinguish between PKA-
regulated and cAMP cargo-regulated abc transcripts, we analyzed
transcript levels in two mutants with constitutively active forms of
PKA in D. discoideum. In cells overexpressing the PKA catalytic
subunit (pkaCOE), abcC13 and abcG21 transcript abundance was
increased more than twofold compared to the wild type (Fig. 3C).
Knockout of the gene that encodes the inhibitory regulatory
subunit of PKA, pkaR, caused an increased in abcA5 and abcG21
transcripts (Fig. 3D). These results implicate abcB3 as the most
likely candidate because its expression was up-regulated in
response to cargo overload in an evolutionarily conserved manner
(Fig. 3A and B), and because it was not regulated by PKA (Fig. 3C
and D).
abcB3 knockdown delays D. discoideum development
We hypothesized that abcB3 exports cAMP during D. discoideum
development and predicted that knockout of the gene would result
in developmental defects, similar to those seen with the inhibitor
experiments (Fig. 1). However, we were unable to generate a knock-
out strain, suggesting that abcB3 might be required for vegetative
growth. As an alternative approach, we created abcB3-RNAi strains.
During development, abcB3 expression increases at 4 h and peaks by
8 h (Miranda et al., 2013; Parikh et al., 2010), so we drove expression
of the abcB3 shRNA using the tgrB1 element of the bidirectional
tgrB1/C1 promoter (Benabentos et al., 2009; Hirose et al., 2011). Since
tgrB1 expression begins at the onset of development, peaks at 4 h,
and remains high until 8 h, we reasoned that the construct would
allow for high levels of shRNA to be present when abcB3 expression
increases and peaks, but not during growth. The bidirectional
promoter also allowed us to co-express GFP from the tgrC1 element,
conﬁrming expression of the abcB3 shRNA by visualizing GFP positive
cells during development. After 10 h of development, wild-type cells
Fig. 2. ABC transporter inhibitors prevent D. discoideum developmental streaming. Cells were developed for 16 h in submerged cultures in the presence of (A) no drug,
(B) dipyridamole, (C) indomethacin, (D) probenecid, and (E) sulfynpyrazone. White arrow indicates the wild type pattern of cells streaming towards an aggregation center.
Images are representative of 3 independent experiments.
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showed low background levels of green ﬂuorescence (Fig. 4A),
whereas two independent strains transformed with the abcB3 shRNA
construct showed strong GFP expression (Fig. 4A). To test abcB3
mRNA abundance in these cells, we measured mRNA levels at
10 h of development by qRT-PCR and found that abcB3 expression
was signiﬁcantly reduced in both strains compared to the wild
type (Fig. 4B). The level of knockdown was different between the
two abcB3-RNAi strains, so we used both strains in subsequent
experiments.
To test the effects of reduced abcB3 expression, we followed
the wild type and both abcB3-RNAi strains during development.
At 6 h, the wild type formed loose aggregates while strain abcB3-
RNAi #1 began to form loose aggregates. Strain abcB3-RNAi #2,
however, failed to form loose aggregates by 6 h (Fig. 5). These
results are consistent with the greater reduction of abcB3mRNA in
strain #2. At 10 h, the developmental differences between the wild
type and the abcB3 RNAi strains were clearest. The wild-type cells
formed tipped aggregates while abcB3-RNAi #1 and #2 cells
remained at the tight aggregate and loose aggregate stages,
respectively (Fig. 5). The developmental delays persisted at 17,
22, and 27 h. By 27 h the majority of the wild-type cells formed
fruiting bodies while the abcB3-RNAi strains did not (Fig. 5). The
developmental delay displayed by the abcB3-RNAi cells is consis-
tent with reduced cAMP export.
abcB3 knockdown reduces extracellular cAMP levels
To test whether abcB3-RNAi expression resulted in altered cAMP
levels, we developed cells for 6 h, collected them and stimulated
cAMP productionwith the cAMP analog 20-deoxy-cAMP. This analog
binds to cell surface cAMP receptors and induces cAMP production
and export, but it is not detected by the cAMP detection method we
used (Van Haastert, 2006; Chen et al., 2002). We found that
stimulation caused a twofold increase in the levels of extracellular
cAMP in the wild type but no signiﬁcant increase in the two abcB3-
RNAi cells (Fig. 6A). This ﬁnding supports the hypothesis that AbcB3
exports cAMP during development. In wild-type cells, intracellular
cAMP levels did not signiﬁcantly differ between unstimulated and
stimulated conditions (Fig. 6B), probably because most of the newly
synthesized cAMP was exported (Fig. 6A). We observed that
intracellular cAMP levels did not increase signiﬁcantly in abcB3-
RNAi cells either (Fig. 6B). We suspect that reduced cAMP export
could cause reduced cAMP production because cAMP levels are
tightly regulated through feedback mechanisms (Saran et al., 2002).
AbcB3 is an exporter of cAMP
To examine the cAMP-exporter activity of AbcB3 more directly,
we tested whether abcB3 expression in an ectopic system could
facilitate cAMP export. We transiently transfected human
HEK293T cells with abcB3 cDNA or with an empty vector (pcDNA3)
control, stimulated the endogenous human adenyl cyclase with
the addition of Forskolin, and measured cAMP levels. In vector
control cells, Forskolin addition caused an increase in extracellular
cAMP levels (Fig. 7A). Ectopic expression of AbcB3 caused an
additional 30% increase in extracellular cAMP accumulation with
Forskolin addition (Fig. 7A; black bars). Moreover, addition of the
ABC-transporter inhibitor Probenicid reduced extracellular cAMP
levels in AbcB3 transfected cells to that of the control cells (Fig. 7A;
gray bars). This increase in cAMP export is accompanied by a
decrease in intracellular cAMP levels after Forskolin treatment in
AbcB3 expressing cells compared to control cells (Fig. 7B; black
bars). Consistent with other studies in mammalian cells, inhibitor
treatment did not raise intracellular cAMP levels likely due to
Fig. 3. Cargo overload increases abc transporter mRNA abundance. (A) D. discoideum and (B) D. purpureum cells were developed on black ﬁlters and treated with 8-Br-cAMP. Six
hours after treatment, we measured transcript levels for the 68 abc transporter genes by qRT-PCR. Fold change (y-axis) was calculated as the ratio of the mRNA abundance
between the treated and the untreated samples. Genes showing more than a two fold increase in abundance are shown. (C) pkaCOE and (D) pkaR– mutant D. discoideum cells
were developed for 6 h and transcript levels of selected abc genes from A were measured by qRT-PCR. Fold increase was calculated as the ratio of the mRNA abundance
between the mutant and the wild type. Bars represent the means and error bars represent standard error of the mean of three independent replications. Note that the scales
of the y-axes are different between the different panels.
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negative feedback regulation of cAMP production (Wielinga et al.,
2003; Ardaillou et al., 1993; Hamet et al., 1989; Patel et al., 1995;
Tjornhammar et al., 1983; Heasley and Brunton, 1985). These data
further support the hypothesis that AbcB3 can export cAMP.
Discussion
Our data suggest that AbcB3 functions as a cAMP exporter
in Dictyostelium. abcB3 mRNA accumulates in response to cAMP
overload in D. discoideum and in the evolutionary distant relative,
D. purpureum, which also uses cAMP as an aggregation chemoat-
tractant. RNAi-mediated knockdown of abcB3 results in decreased
extracellular cAMP levels and leads to perturbed D. discoideum
development and ectopic expression of abcB3 is sufﬁcient to
increase cAMP export in mammalian cells.
Pharmacological inhibition of ABC transporters disrupted
developmental aggregation and caused developmental delay,
suggesting that ABC transporters are involved in cAMP export.
The ABC transporter inhibitors used are chemically distinct and
their potential off-target effects are probably different. However,
all inhibitors disrupted development similarly and in a manner
consistent with a defect in cAMP export (Wang and Kuspa, 1997),
suggesting that their common effects are due to reduced cAMP
export.
In our genetics studies we used three criteria to select abc
genes for further analysis: (1) cAMP-induced transcriptional
regulation, (2) PKA-independent transcriptional regulation, and
(3) evolutionary conservation of cAMP-dependent transcriptional
regulation. Remarkably, of the 68 abc genes, abcB3 was the only
gene that satisﬁed all three criteria. While our data suggests that
abcB3 is indeed a cAMP exporter, we have not excluded the
possibility that other cAMP-responsive abc genes encode potential
cAMP exporters.
In gene silencing experiments, we observed a developmental
delay that began at the aggregation stage. The initiation of the
delay at the aggregation stage is in line with a defect in cAMP
signaling (Kessin, 2001; Saran et al., 2002; Meima and Schaap,
1999). The delay persisted throughout development; however,
some cells were able to form fruiting bodies eventually. The lack
of complete developmental arrest suggests that there are other
cAMP exporters in D. discoideum. This would not be surprising
considering that ABC proteins are promiscuous transporters
(Cheepala et al., 2013; Anjard and Loomis, 2002; Annilo et al.,
2006; Sarkadi et al., 2006; Dean et al., 2001; Frelet and Klein,
2006; Linton, 2007; van de Water et al., 2005). A more interesting
rationale for multiple cAMP exporters is that D. discoideum
development is controlled by several cAMP receptors (CAR1-4)
expressed at different times and in speciﬁc cell types with varying
degrees of afﬁnity to cAMP (Prabhu and Eichinger, 2006; Saxe
et al., 1991). It is conceivable that multiple cAMP exporters exist
Fig. 4. Expression of abcB3 shRNA reduces abcB3 transcripts. Wild-type and abcB3 shRNA expressing cells were developed on black ﬁlters for 10 h as indicated. (A) GFP
expression, an indicator of transformation efﬁciency, was determined by ﬂuorescence microscopy. (B) abcB3 transcript levels were measured by qRT-PCR and calculated as
the ratio of the mRNA abundance between the mutant cells and the wild type (y-axis). Bars represent the means and error bars represent standard error of the mean of three
independent replications.
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Fig. 5. abcB3 knockdown delays D. discoideum development. Wild-type and abcB3 shRNA expressing cells were developed on black ﬁlters and images taken at the indicated
times. Images are representative of results from 3 independent experiments. Two independent strains expressing abcB3 shRNA constructs are shown. Scale bars for each row
are shown in the left panels.
Fig. 6. abcB3 knockdown reduces extracellular levels of cAMP in D. discoideum. Wild-type and abcB3 shRNA expressing cells were developed on black ﬁlters for 6 h,
disaggregated, and treated with 20-deoxy-cAMP. We measured extracellular (A) and intracellular (B) cAMP levels (pmol/2105 cells). Bars represent the means and error
bars represent standard error of the mean of four independent replications. npr0.02.
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and are also differentially expressed temporally and spatially
during multicellular development. The other cAMP-responsive
abc genes we identiﬁed might compensate when abcB3 is down-
regulated. Additionally, it is still formally possible that Adenylyl
Cyclase A exports cAMP because the experiments done to test its
potential export activity only showed that it was not the only
exporter (Pitt et al., 1993).
Another explanation for a lack of developmental arrest with
abcB3-RNAi is that abcB3 knockdown was transient and incom-
plete. We were unable to knockout the abcB3 gene, which suggests
that it might have an additional role in D. discoideum growth.
Instead, we used the tgrB1-C1 promoter to drive abcB3-RNAi
expression. The tgrB1-C1 promoter becomes active at around 4 h
of development in all cells and remains active for about 6 h, after
which it is mostly active in prestalk cells (Parikh et al., 2010;
Benabentos et al., 2009; Hirose et al., 2011; Loomis and Shaulsky,
2011). It is possible that once the tgrB1-C1 promoter became
inactive, the levels of abcB3-RNAi expression were insufﬁcient to
reduce the accumulation of abcB3 mRNA, and the cells were able
to recover and develop. The reversibility of the phenotype is also
supported by the observation that the ABC-transporter inhibitors
effects were reversible. Both insufﬁcient knockdown and the
presence of multiple cAMP exporters likely contribute to the
developmental phenotype observed in our experiments.
We measured cAMP levels inside and outside of D. discoideum
cells and found a positive relationship between AbcB3 expression
and levels of extracellular cAMP. We do not have direct binding
evidence or structural data to further support that AbcB3 exports
cAMP. It is therefore formally possible that AbcB3 may function in
some ancillary capacity to the real cAMP exporter. However, the
most compelling evidence that AbcB3 exports cAMP is that
expressing abcB3 in mammalian cells was sufﬁcient to increase
extracellular cAMP levels without any additional D. discoideum
genes. Moreover, ABC transporter inhibitors blocked that increase
in extracellular export.
ABC transporters are present in every domain of life, transport
an incredible array of molecules, and show a considerable level of
functional and structural homology from bacteria to vertebrates.
Human ABC transporters can export cAMP, and our data suggest
that this function is also conserved in Dictyostelium. The physio-
logical signiﬁcance of cAMP export is clear in D. discoideum
(Alvarez-Curto et al., 2005; Prabhu and Eichinger, 2006). Very
little is known about the function of cAMP efﬂux in mammals
(Hamet et al., 1989; Tjornhammar et al., 1983), but the fact that it
exists suggests that the ability to export cAMP evolved before the
split between animals and amoebae.
Much remains to be examined with regards to cAMP export and
AbcB3 function and regulation. From a broader perspective, there are
many abc genes in the D. discoideum genome, but their cargoes and
functions are largely unknown. Multidrug resistance caused by ABC
transporters has been an area of focused research and ABC transpor-
ter dysfunction causes 17 known genetic disorders (Annilo et al.,
2006). Our previous work (Miranda et al., 2013) and this study
provide a framework for studying ABC transporter function in D.
discoideum not only in the context of ameba biology but also in the
context of human biology and disease.
Methods
Dictyostelid strains, growth, and development
D. discoideum AX4 (wild type), pkaR–, and pkaCOE strains are
described in Shaulsky et al. (1998), Knecht et al. (1986), Anjard
et al. (1992) and Mann et al. (1992). D. purpureum DpAX1 is
described in Sucgang et al. (2011). Cells were grown in shaking
suspension at 220 rpm at 221C in HL5 medium supplemented with
penicillin (50 U/mL) and streptomycin (300 mg/mL) (Sussman,
1987). abcB3 shRNA expressing cells were maintained as above
and supplemented with G418 (10 μg/mL). For development on
black nitrocellulose ﬁlters, cells were harvested at the logarithmic
growth phase and washed twice with KK2 buffer (16.3 mM
KH2PO4, 3.7 mM K2HPO4, pH 6.2). Cells (5107) were deposited
onto a 5 cm ﬁlter atop a paper pad saturated with 2 mL PDF buffer
(9.2 mM K2HPO4, 13.2 mM KH2PO4, 20 mM KCl, 1.2 mM MgSO4,
pH 6.5) and incubated in a dark humid chamber at 221C. Where
indicated, vehicle control or 1 mM of the ABC inhibitors Indo-
methacin, Probenecid, Dipyridamole, or Sulfynpyrazone (Sigma-
aldrich, MO, USA) was added to the PDF buffer. For developmental
streaming assays, 1.56106 cells/cm2 were deposited in a 12 well
plate (BD Biosciences, CA, USA) under 666 μL of PDF containing
vehicle control or 50 μM of one of the ABC transporter inhibitors.
Cells were incubated at 221C in a dark chamber and imaged at
16 h.
Fig. 7. Ectopically expressed abcB3 exports cAMP in mammalian cells. HEK293T cells were transiently transfected with pcDNA3.1 (empty vector control) or an expression vector
for abcB3 cDNA, as indicated. Transfected cells were unstimulated, stimulated with Forskolin alone, or with Forskolin and the ABC transporter inhibitor Probenecid, as
indicated. We measured extracellular (A) and intracellular (B) cAMP levels (pmol/104 cells). Bars represent the means and error bars represent standard error of the mean of
three independent replications. npr0.02.
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Plasmids, transformations, and transfections
The abcB3 RNAi plasmid was constructed as described in
(Martens et al., 2002). Brieﬂy, bases 80–480 of the abcB3 coding
sequence followed by sequences complementary to bases 302–480
were subcloned into an expression vector under control of the
bidirectional tgrB1/tgrC1 promoter to facilitate RNAi during devel-
opment. The ﬁnal vector contained abcB3 sequences controlled by
the tgrB1 promoter and a green ﬂuorescence protein (GFP) gene
controlled by the tgrC1 promoter, resulting in co-expression of
abcB3 RNAi sequences and GFP. This plasmid was transformed into
the AX4 strain, and G418 resistant clones were selected as
described in (Benabentos et al., 2009). Independent strains were
isolated from independent transformations. abcB3 knockdownwas
conﬁrmed by quantitative RT-PCR (qRT-PCR).
abcB3 cDNA was cloned in the pcDNA3.1(þ) plasmid (Invitro-
gen, CA, USA). HEK293T cells (Nam et al., 2011a, 2011b) were
maintained in DMEM (Invitrogen) containing 10% fetal bovine
serum. Cells were transfected with abcB3 expression vectors or
empty pcDNA3.1 plasmid using Lipofectamine 2000 (Invitrogen)
according to the manufacturer's recommended protocol. Twenty-
four hours after transfection, cells were counted, and re-seeded in
a 6 well plate at 4.16104 cm2. The cells were used for cAMP
export experiments 72 h post-transfection.
mRNA abundance analysis
D. discoideum and D. purpureum were developed on black
nitrocellulose ﬁlters at 221C for 0, 3, or 6 h. Cells were harvested
with KK2 buffer containing 0.02 M EDTA, and 3107 cells were
re-suspended in 30 mL of KK2 buffer containing no cargo or
20 mM of 8-Br-cAMP. Cells were incubated in shaking suspension
at 220 rpm for 2 h, harvested by centrifugation, and re-suspended
in 1 mL of Trizols (Life technologies, CA, USA). Total RNA was
extracted according to the manufacturer's recommended protocol.
RNA was treated with DNAse as described (Benabentos et al.,
2009), cDNA prepared using Superscript II reverse transcriptase as
described (Parikh et al., 2010), and quantitative reverse transcrip-
tase PCR (qRT-PCR) performed with oligonucleotides speciﬁc to
each abc gene as described (Miranda et al., 2013). Two indepen-
dent incubation experiments with three technical replicates of the
qRT-PCR were performed. To determine abc transcript abundance
in pkaR and pkaCOE strains, experiments and analysis were
performed similarly but without 8-Br-cAMP treatment. To conﬁrm
abcB3 knockdown, qRT-PCR was performed as above after 10 h of
development.
Intracellular and extracellular cAMP measurement
These experiments were conducted as described (Van Haastert,
2006). Brieﬂy, D. discoideum cells were developed on black
nitrocellulose ﬁlters for 4–6 h, harvested using KK2 buffer contain-
ing 0.02 M EDTA, and re-suspended at 5107 cells/mL in KK2
buffer. Using 4106 cells of the suspension (80 mL), cAMP export
was stimulated with 20 mL of a stimulus solution containing 50 mM
2'-deoxy-cAMP and 50 mM DTT for 5 min. Samples were centri-
fuged for 5 s at 14,000g and intracellular and supernatant fractions
were separated. Stimulation was stopped by adding 100 mL of 3.5%
(v/v) perchloric acid to fractions and stored at 201C for radi-
olabeled competitive cAMP binding assays.
Human cells were washed with 2 mL of 1 phosphate buffer
saline (PBS, Invitrogen) without dislodging and incubated for 30 min
with 1 mL of PBS containing 0.2 mM 3-isobutyl-1-methylxanthine
(IBMX) (Sigma-Aldrich), or 0.2 mM IBMX and 100 mM Forskolin
(Sigma-Aldrich), or 0.2 mM IBMX, 100 mM of Forskolin, and 100 mM
Probenecid. Cells were harvested, centrifuged at 600g for 5 min, and
the cells suspension was separated into supernatant (extracellular
fraction) and pellet (intracellular fraction). Stimulation was termi-
nated by adding 100 mL of 3.5% (v/v) perchloric acid to the fractions.
Samples were stored at 201C for radiolabeled competitive cAMP
binding assays.
cAMP measurement was assayed as described in Van Haastert
(2006). Brieﬂy, samples were neutralized using a 50% saturated
solution of KHCO3, centrifuged, and the supernatant collected for
the assay. 20 mL of tracer (0.4 mCi/mL of 3H-cAMP), 20 mL of sample
or standard, and 40 mL of cAMP binding protein prepared from
beef muscle (Chen et al., 2002) were combined and incubated on
ice for 1.5 h. Binding reactions were stopped by addition of 40 mL
activated charcoal. 50 mL of the supernatant was used to measure
radioactivity via scintillation counting, and the amount of cAMP in
samples was determined by comparing samples to standard
amounts of cAMP as described (Van Haastert, 2006). For each
experiment, samples were prepared in at least duplicates.
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